What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
His primary scientific interests are in Internal medicine, Endocrinology, Biochemistry, Lipoprotein and High-density lipoprotein.
Alan M. Fogelman has researched Endocrinology in several fields, including Inflammation, Proinflammatory cytokine and Coronary artery disease.
His biological study spans a wide range of topics, including Apolipoprotein E, In vivo and Monocyte.
His Monocyte research incorporates elements of Endothelial stem cell, Macrophage colony-stimulating factor, Dose–response relationship, Biological activity and Endothelium.
The concepts of his High-density lipoprotein study are interwoven with issues in Lipid oxidation, Statin, Simvastatin, Lipoprotein and Rheumatology.
His study in the field of Apolipoprotein B is also linked to topics like Ultra rapid freezing.
His most cited work include:
- Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. (1551 citations)
- Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells (1025 citations)
- Antiinflammatory Properties of HDL (1019 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Endocrinology, Biochemistry, Apolipoprotein B and Lipoprotein.
His is doing research in Cholesterol, High-density lipoprotein, LDL receptor, Monocyte and Paraoxonase, both of which are found in Internal medicine.
In his study, Endothelial stem cell is strongly linked to Endothelium, which falls under the umbrella field of Monocyte.
His work carried out in the field of Endocrinology brings together such families of science as Lesion, Inflammation, Proinflammatory cytokine, Serum amyloid A and Apolipoprotein E.
The Inflammation study combines topics in areas such as Oxidative stress and Small intestine.
Alan M. Fogelman interconnects Molecular biology and In vivo in the investigation of issues within Biochemistry.
He most often published in these fields:
- Internal medicine (48.60%)
- Endocrinology (45.53%)
- Biochemistry (30.73%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (48.60%)
- Endocrinology (45.53%)
- Inflammation (17.60%)
In recent papers he was focusing on the following fields of study:
Alan M. Fogelman mostly deals with Internal medicine, Endocrinology, Inflammation, Apolipoprotein B and Lipoprotein.
His Internal medicine research includes elements of Peptide mimetic and Hydroxyeicosatetraenoic acid.
His Endocrinology research is multidisciplinary, relying on both Serum amyloid A, Lysophosphatidic acid and Oxidative phosphorylation.
His study in Inflammation is interdisciplinary in nature, drawing from both Tumor necrosis factor alpha, Small intestine, Inflammatory bowel disease and Mechanism of action.
Lipoprotein is the subject of his research, which falls under Biochemistry.
He works mostly in the field of Biochemistry, limiting it down to concerns involving In vivo and, occasionally, Angiogenesis.
Between 2012 and 2021, his most popular works were:
- High-Density Lipoprotein Vascular Protective Effects, Dysfunction, and Potential as Therapeutic Target (193 citations)
- Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis (100 citations)
- Diesel Exhaust Induces Systemic Lipid Peroxidation and Development of Dysfunctional Pro-Oxidant and Pro-Inflammatory High-Density Lipoprotein (95 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His primary areas of investigation include Internal medicine, Endocrinology, Apolipoprotein B, Inflammation and Lipoprotein.
His research combines Cell growth and Internal medicine.
His research in Endocrinology intersects with topics in Serum amyloid A and Lysophosphatidic acid.
His Apolipoprotein B research integrates issues from Hypoxia, Inflammatory bowel disease, Chromosomal translocation, Myeloid and Computational biology.
The study incorporates disciplines such as Cyclooxygenase, Barrier function and Intestinal epithelium in addition to Inflammation.
His research integrates issues of Reactive oxygen species, Hemopexin, Molecular biology, Pharmacodynamics and Apolipoprotein E in his study of Lipoprotein.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
